Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non-small cell lung cancer.

Insurance status provided the single most protective effect against metastatic presentation. This benefit varied for minorities despite similar insurance. Reducing metastatic disease presentation rates requires addressing social barriers to care independent of insurance.